In 2026, shell egg sales represented 85% of total net sales compared to 94.5% in 2025. Specialty eggs drove a greater portion of shell egg sales, accounting for 39.6% of total shell egg sales compared to 33%. Specialty eggs and prepared foods combined accounted for 42.8% of net sales compared to 32.4%. None of this happens without our people. I want to sincerely thank our teams across the organization whose disciplined focus and commitment to excellence drive the operational and financial performance that u ...

Cal-Maine Foods (NasdaqGS:CALM) Q2 2026 Earnings Call January 07, 2026 09:00 AM ET Company ParticipantsBenjamin Mayhew - VP of Equity ResearchMax Bowman - VP and CFOHeather L. Jones - Equity ResearchSherman Miller - President and CEOConference Call ParticipantsLeah Jordan - Equity Research AnalystPooran Sharma - Equity Research AnalystBen Klieve - Equity Research AnalystOperatorGood morning, everyone, and welcome to the Cal-Maine Foods second quarter fiscal 2026 earnings conference call. All participants ar ...

Core Viewpoint - Fluor is facing significant near-term challenges, including a stock decline of 20% in 2025, while the S&P 500 rose by 17% during the same period [1] Financial Performance - Fluor's second-quarter earnings report on August 1 missed analysts' expectations, leading to a reduction in its full-year outlook and the disclosure of cost overruns, scheduling delays, and design problems in major projects [2] - Revenue for Fluor increased by 5% in 2024, but adjusted EBITDA fell by 14% due to lower profits from its energy solutions segment and fewer contracts [7] - On a GAAP basis, Fluor's earnings per share surged from $0.54 in 2023 to $12.30 in 2024, primarily due to the sale of shares in NuScale Power [8] Legal and Operational Issues - The unexpected guidance reduction and execution issues led to a class action lawsuit from investors alleging misleading statements regarding growth prospects [4] - Fluor agreed to pay $653 million to Santos to resolve a legal dispute, which was recorded as a revenue reduction, further impacting its financial performance [5] Backlog and Contracting - Fluor's backlog shrank year over year for four consecutive quarters, as it completed existing projects faster than it could secure new contracts [9] - The company shifted towards smaller, lower-risk contracts to diversify its business and reduce dependence on large infrastructure projects [10] Future Outlook - Analysts expect Fluor's revenue and EBITDA to decline by 4% and 19% respectively for the full year, but anticipate a recovery in 2026 with expected increases of 7% and 10% [11] - The company's low valuation, with an enterprise value of $4.5 billion, suggests limited downside potential, and activist investor Starboard Value is pushing for monetization of its stake in NuScale [12] - If Fluor resolves its execution issues and grows its backlog, there is potential for gradual stock price recovery over the next 12 months [13]

The Zacks Investment Bank industry is set to benefit from clarity on trade and monetary policy, a resilient economy and lower financing costs, which will boost M&As and underwriting prospects in 2026. Trading revenues are likely to remain strong as geopolitical risks and tariff concerns help sustain market volatility and client activity. Meanwhile, rising investments in AI, technology and platforms may weigh on costs in the near term but are expected to enhance long-term operating efficiency. Hence, industr ...

Core Viewpoint - Agape ATP Corporation's stock experienced significant volatility, with a notable after-hours surge of 43.89% to $0.13, despite a prior closing price of $0.090, which represented a decline of 25.86% [1][2]. Company Statement - The company addressed the recent stock volatility, stating that management is unaware of any undisclosed corporate developments or adverse operating conditions that could explain the price fluctuations [2]. - Agape ATP confirmed that its operations are continuing as usual [2]. Management Commentary - Prof Dato' Sri Dr How Kok Choong, the founder and Global Group CEO, emphasized the company's commitment to diversifying its businesses in health and wellness, as well as sustainable green energy, to enhance sustainable equity performance for investors [3]. - The company pledged to maintain timely disclosures of developments through regulatory filings [3]. Recent Financial Performance - For the third quarter, Agape ATP reported revenue of $370,590, a decrease from $465,500 in the second quarter, with a loss of $0.01 per share, consistent with the previous quarter [4]. Trading Metrics - Year-to-date, ATPC shares have declined by 92.24%, with a market capitalization of $4.55 million. The stock has traded within a 52-week range of $0.05 to $2.93 [5]. - Benzinga's Edge Stock Rankings indicate a negative price trend for ATPC across all time frames [5].

Core Viewpoint - Kewaunee Scientific Corporation experienced a decline in share price despite significant revenue growth, indicating potential challenges in profitability and operational efficiency [1][2][10]. Earnings & Revenue Performances - For the quarter ended October 31, 2025, Kewaunee reported net sales of $70.1 million, a 46.8% increase from $47.8 million in the same period last year [2]. - Net earnings attributable to Kewaunee decreased to $2.4 million from $3 million year-over-year, with diluted earnings per share falling to 82 cents from $1.01 [2]. Profitability Metrics - Pre-tax earnings declined 12.2% year-over-year to $3.5 million, while EBITDA increased to $5.8 million from $4.9 million, reflecting improved operating scale despite margin pressures [3][10]. Key Business Metrics - Order backlog was $192.9 million as of October 31, 2025, up from $184.4 million a year earlier but down from $214.6 million at the end of fiscal 2025 [4]. - Total cash on hand decreased to $13.7 million from $17.2 million at April 30, 2025, while working capital improved to $67.8 million from $60 million year-over-year [4]. Debt and Balance Sheet - Long-term debt decreased to $58.2 million from $60.7 million, and the debt-to-equity ratio improved to 0.88-to-1 from 0.99-to-1, indicating a strengthening balance sheet [5]. Segment Performance - Domestic sales increased 51.7% year-over-year to $55.2 million, driven by the acquisition of Nu Aire, Inc., although net earnings in the domestic segment fell to $3.6 million from $4.5 million due to lower manufacturing volumes [6]. - International sales rose 31% year-over-year to $14.9 million, with net earnings improving to $0.6 million from $0.4 million [6]. Management Commentary - Management noted volatility in project delivery timing but emphasized strong quoting and booking activity, which supports a robust backlog [7][11]. - The performance of Nu Aire was highlighted as a key factor offsetting weaknesses in the legacy construction-driven business [8]. Factors Influencing Results - Revenue growth was attributed to higher sales volumes in both Domestic and International segments, with the Nu Aire acquisition contributing significantly [9]. - Profitability pressures stemmed from lower manufacturing volumes in the Domestic business and increased operating expenses related to integration and corporate investments [10]. Future Outlook - Management expects continued volatility in project delivery timing but remains confident in strong backlog levels and sustained demand into fiscal 2027 [11]. - Early repayment of seller notes was noted as a positive development for the balance sheet and potential future acquisitions [11]. Other Developments - The quarter reflected ongoing integration of Nu Aire, with related fees impacting results but at lower levels than the previous year [12].

Core Insights - Boeing Company benefits from a diversified business model that includes commercial airplanes, defense systems, space technology, and global services, which helps mitigate financial risks [1][5] - The company's various segments provide stability during economic downturns, particularly through long-term government contracts in defense and space [2][5] - Boeing's extensive product line and shared resources across divisions enhance operational efficiency and cost management [3] Business Segment Contributions - For the nine months ended September 30, 2025, Boeing's revenue breakdown was approximately 46% from Commercial Airplanes, 30% from Defense, Space & Security, and 24% from Global Services, indicating a balanced revenue stream [4] - This diversification allows Boeing to maintain financial stability across different market conditions [5] Earnings Estimates and Stock Performance - The Zacks Consensus Estimate indicates a year-over-year improvement in EPS of 53.24% for 2025 and 110.15% for 2026, reflecting strong growth potential [8][9] - Boeing's shares have increased by 22.1% over the past year, outperforming the industry average growth of 15.8% [9][13] Valuation Metrics - Boeing's forward 12-month price-to-sales (P/S) ratio is 1.61X, which is below the industry average of 2.44X, suggesting the stock is trading at a discount [11]

ab 4 December 2025 China auto supply chain branching out into AR/AI glasses The development of AI glasses is progressing rapidly and represents a significant frontier in AI applications. Major tech companies in China (such as Xiaomi, Ali Quark, and Huawei) and overseas (such as Meta, Google, and Apple) have been actively investing in this area. Recently, we have also seen some companies outside tech entering the AI glasses field; for instance, Li Auto just launched its first AI glasses - Livis. Auto parts c ...

Core Insights - Gilead has experienced significant growth in its base business over the past three years, indicating the start of a long growth cycle for the company [2] - The company has diversified its operations into various therapeutic areas, including virology, HIV, oncology, and inflammation, which has begun to yield positive results [3] Financial Performance - Base revenues, excluding COVID antiviral sales, grew by 7% year-over-year in 2023, following an 8% growth in the previous year [4] - Despite facing a $1.1 billion headwind from Medicare Part D reform, the company’s base business is projected to grow by 9% to 10%, with a current growth rate of 5% [4]

Summary of inTEST Corporation FY Conference Call Company Overview - **Company**: inTEST Corporation (NYSEAM: INTT) - **CEO**: Nick Grant - **CFO**: Duncan Gilmour - **Current Revenue**: Approximately $130 million, up from under $55 million five years ago [2][3] Industry Insights - **Market Focus**: Primarily serves the semiconductor testing market, with diversification into automotive, aerospace defense, and industrial markets [3][4] - **Key Technologies**: - Electronic tests for back-end semiconductor applications - Environmental technologies for thermal control and testing - Process technologies including induction heating and image capture systems [5][6][8] Financial Performance - **Q3 Orders**: Strong performance with orders reaching $37.6 million, particularly in automotive/EV and defense/aerospace sectors [17][18] - **Backlog**: Ended Q3 with a backlog of just under $50 million, indicating recovery from previous declines [18] - **Q3 Revenue**: Reported revenue of $26 million, slightly below expectations due to delays in shipments [19][20] - **Gross Margin**: Q3 gross margin at 41.9%, consistent with previous quarters [20] - **Operating Cash Flow**: Generated $3.1 million in operating cash flow for Q3, with a total of $7 million for the first nine months of 2025 [22] Growth Strategy - **Vision 2030**: Aiming for revenue growth to $235 million-$285 million by 2030 through both organic and inorganic means [10] - **New Product Revenue**: Currently at 17%, with a target of over 25% [26] - **Acquisition Strategy**: Targeting companies in the $20 million-$40 million range to enhance existing technologies and expand geographic presence [14][15] Market Trends and Challenges - **Automotive Sector**: Experienced a slump in EV orders as OEMs shifted focus back to hybrids and combustion engines, but new projects for 2027 model years are expected to drive future growth [31][32] - **Technological Challenges**: Delays in new product shipments due to technical challenges, particularly in the AlphaMation and AstroLogics divisions [27][28] Key Takeaways - **Diversification**: Successful diversification into multiple markets has reduced reliance on the semiconductor sector, which now constitutes just over a third of total business [3][19] - **Innovation Focus**: Continuous investment in innovation and new product development is crucial for maintaining competitive advantage [10][11] - **Financial Health**: Strong balance sheet with $20 million in cash and a plan to be close to debt-free by the end of 2026 [24][23] Conclusion - inTEST Corporation is well-positioned for future growth with a diversified portfolio, strong order backlog, and a clear strategic vision. The company is navigating current market challenges while focusing on innovation and operational excellence to drive long-term success.